RACHEL SCHIFF to Drugs, Investigational
This is a "connection" page, showing publications RACHEL SCHIFF has written about Drugs, Investigational.
Connection Strength
0.219
-
Advances in breast cancer treatment and prevention: preclinical studies on aromatase inhibitors and new selective estrogen receptor modulators (SERMs). Breast Cancer Res. 2003; 5(5):228-31.
Score: 0.219